Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Pranlukast and mirabegron may work as new diabetes drugs.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Finasteride reduces movement issues in Parkinson's disease rats.

These medications for BPH have known risks and may have new side effects.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

New progesterone-based compounds can block male hormones.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

FGF-2&D/P nanoparticles can help treat hair loss.

New steroids were effective in blocking male hormone receptors in hamster prostates.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

DPP may help hair regrowth by improving blood vessel function under stress.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Drugs like PDEI may help hair disorders like AGA.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Finasteride helps improve treatment for benign prostatic hyperplasia.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.